Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor

Clinical trial NCT06572631 · WITHDRAWN

Trial details

NCT number: NCT06572631
Sponsor: City of Hope Medical Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Acute Myeloid Leukemia Recurrent Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory Myelodysplastic Syndrome

Start date: 2025-06-07
Primary completion: 2026-12-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.